In conjunction with two international players of repute, the IMS Institute and the WHO, we have compiled two technical reports, which will set the agenda for discussions during the summit. We are also writing a discussion document summarising the most important findings for policy makers and ministers. In consultation with the ministry and other parties involved, we are setting up the programme for the day and making suggestions for follow-up activities. We will brief the main speakers at the summit, such as the CEO of one of the world’s leading pharmaceutical companies, various ministers and eminent academics.
